SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001019056-21-000145
Filing Date
2021-02-17
Accepted
2021-02-17 21:02:26
Documents
1
Period of Report
2021-01-29

Document Format Files

Seq Description Document Type Size
1 lamothe.html 4  
1 lamothe.xml 4 6306
  Complete submission text file 0001019056-21-000145.txt   7635
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Issuer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2401 4TH AVENUE SUITE 1050 SEATTLE WA 98121
Business Address
Lamothe Jeffrey G. (Reporting) CIK: 0001679967 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37746 | Film No.: 21647349